• Copay, Reimbursement and Access Congress

    Hilton East Brunswick Hotel East Brunswick, NJ, United States

    With increased complexity and nuance, the need for innovative copay and reimbursement strategies is now. Copay, Reimbursement and Access Congress is bringing together seasoned experts this November to deliver the most up-to-date insights necessary to enhance patient affordability, ensure program sustainability and navigate the regulatory landscape. Remaining compliant has never been more complex and program...

  • EU GMP Annex 11 action plan: Assessment, strategy and digital solutions for compliance

    Join Stephen Ferrell, Chief Product Officer at Valkit.ai as he provides a critical analysis of one of the most significant regulatory updates to impact pharmaceutical computerized systems in over a decade. The proposed EU GMP Annex 11 revision transforms European compliance requirements from risk-based guidance to prescriptive technical specifications, introducing mandatory audit trails for all...

    Free
  • The future is now: are you keeping pace with oligo synthesis optimization?

    The oligonucleotide market is moving fast. Now is an exciting time with 20 therapeutics on the market and so many oligos being developed for future treatments. While the market traditionally centred around the outstanding and essential work with rare diseases, some blockbusters are emerging for much larger patient indications. We know that you’re the expert...

    Free
  • Unpacking pDNA processes: Capacity, complexity, and cutting-edge solutions (FREE WEBINAR)

    As the demand for plasmid DNA (pDNA) continues to surge across gene therapies, mRNA vaccines, and cell therapies, manufacturers are facing growing pressure to expand capacity with speed and precision. But scaling pDNA production is far from straightforward. Unforeseen complexities in areas like facility design or process innovation often leads to costly delays and missed...

    Free
  • BVS’ Biotech Innovation & Vendor Expo at the Cambridge Marriott

    We are very excited to announce our indoor Biotech Innovation & Vendor Expo at the Cambridge Marriott. Mark your calendars for a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. This biotech community event will bring together researchers from local biotech/pharma accounts in Cambridge/Boston...

  • STAT@JPM: Health Care at a Crossroads

    San Francisco, CA San Francisco, CA, United States

    Never has so much been at stake when it comes to investments in health care. All kinds of uncertainty — political, social, and scientific — stand between new preventatives, treatments, and cures and the patients who need them. But never has investment been more important either. Join us for a look at what is at...

  • The Science of CRO Selection: Insights from $2B+ in Vendor Selections

    Selecting the right CRO is one of the most critical decisions in clinical development, yet rarely a straightforward one. Sponsors often find that comparing CRO proposals isn’t an apples-to-apples exercise — with variations in assumptions, timelines, and resource structures making true comparisons difficult. This session draws on insights from more than $2B in CRO selections...

    Free
  • Philadelphia Life Sciences Conference

    Philadelphia Philadelphia, PA, United States

    Greater Philadelphia sits at the forefront of a dynamic life sciences evolution, where strategic decision-making today will shape the trajectory of the region’s biotech and innovation economy for years to come. As funding landscapes shift, groundbreaking research emerges, and tenant demands evolve, stakeholders across commercial real estate, including developers, investors, and brokers, need critical insights...

  • 2025 Boston Biotech Summit

    Somerville Somerville, MA, United States

    What You'll Learn: How will lower interest rates influence biotech funding, investment flows, and real estate capital allocation in 2025? With a record volume of new lab and GMP supply delivering this year, how can owners make their assets stand out in a crowded market? Is renewed activity in biotech IPOs and venture funding a...

  • Streamline the Critical Path for Gene Therapy: Key Considerations for the AAV Analytical Lifecycle

    AAV vectors offer clear benefits for gene therapy, and continued advances in technology have increased target specificity, improved potency, and intensified production efficiency. Even with significant attention early in development, analytical activities for gene therapy often land on the critical path. This webinar provides considerations for phase-appropriate AAV characterization and release activities from pre-clinical to...

    Free